2020 |
Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency. Chung JH, Hong SH, Seo N, Kim TS, An HJ, Lee P, Shin EC*, Kim HM*. [Cytokine. 2020 Jan;125:154833.(2020)] Abstract |
2019 |
Fabrication of rigidity and space variable protein oligomers with two peptide linkers. Choi H, Park H, Son K, Kim HM, Jung Y. [Chemical Science. 2019 Nov 28; 10(44), 10428-10435.(2019)] Abstract |
2019 |
Pro-angiogenic ginsenosides F1 and Rh1 inhibit vascular leakage by modulating NR4A1. Kang JI, Choi Y, Cui C-H, Lee D*, Kim SC*, Kim HM*. [Sci. Rep. 2019 Mar 14;9(1):4502.(2019)] Abstract |
2019 |
Synaptic organizer: Slitrks and type IIa receptor protein tyrosine phosphatases. Won SY, Lee P, Kim HM*. [Curr Opin Struct Biol. 2019 Feb; 54:95-103.(2019)] Abstract |
2018 |
HMGB1: LPS delivery vehicle for Caspase-11-mediated pyroptosis (Preview). Kim HM*, Kim YM*. [Immunity. 2018 Oct 16;49(4):582-584.(2018)] |
2018 |
Structural basis for LAR-RPTP-mediated synaptogenesis. Won SY, Kim HM*. [Mol Cells. 2018 Jul 31;41(7):622-630.(2018)] |
2018 |
Multi-paratopic VEGF decoy receptor have superior anti-tumor effects through anti-EGFRs and targeted anti-angiogenic activities. Lee DH, Lee MY, Seo Y, Hong HJ, An HJ, Kang JS*, Kim HM*. [Biomaterials. 2018 Apr 16;171:34-45.(2018)] |
2018 |
Four-fold channel-nicked human ferritin nanocages for active drug loading and pH-responsive drug release. Ahn B, Lee S-G, Yoon HR, Lee JM, Oh HJ, Kim HM*, Jung Y*. [Angew Chem Int Ed Engl. 2018 Mar 5;57(11):2909-2913.(2018)] |